Israel Englander Verastem, Inc. Transaction History

Millennium Management LLC

$199 Billion
Q3 2024

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$0.39 - $0.71 $206,315 - $375,599	-529,013 Reduced 48.92%	552,329 $229,000
Q4 2022 Feb 14, 2023	SELL	$0.33 - $10.44 $706,513 - $22.4 Million	-2,140,950 Reduced 66.44%	1,081,342 $435,000
Q3 2022 Nov 14, 2022	SELL	$0.92 - $11.16 $1.78 Million - $21.6 Million	-1,932,238 Reduced 37.49%	3,222,292 $2.74 Million
Q2 2022 Aug 15, 2022	BUY	$1.02 - $1.83 $4.24 Million - $7.61 Million	4,158,108 Added 417.3%	5,154,530 $5.98 Million
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $481,389 - $953,696	-454,141 Reduced 31.31%	996,422 $1.41 Million
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $884,673 - $1.38 Million	431,548 Added 42.35%	1,450,563 $2.97 Million
Q3 2021 Nov 15, 2021	SELL	$2.54 - $4.07 $970,704 - $1.56 Million	-382,167 Reduced 27.27%	1,019,015 $3.14 Million
Q2 2021 Aug 16, 2021	BUY	$2.57 - $4.85 $3.6 Million - $6.8 Million	1,401,182 New	1,401,182 $5.7 Million
Q4 2020 Feb 16, 2021	SELL	$1.15 - $2.4 $1.17 Million - $2.44 Million	-1,016,838 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$1.11 - $1.68 $1.35 Million - $2.05 Million	-1,220,585 Reduced 54.55%	1,016,838 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$1.69 - $4.2 $2.15 Million - $5.35 Million	1,272,643 Added 131.91%	2,237,423 $3.85 Million
Q1 2020 May 14, 2020	BUY	$1.26 - $3.38 $1.16 Million - $3.12 Million	922,761 Added 2196.06%	964,780 $2.55 Million
Q4 2019 Feb 14, 2020	SELL	$0.86 - $1.44 $10,655 - $17,841	-12,390 Reduced 22.77%	42,019 $56,000
Q3 2019 Nov 14, 2019	SELL	$1.21 - $1.59 $2.13 Million - $2.8 Million	-1,762,372 Reduced 97.01%	54,409 $65,000
Q2 2019 Aug 15, 2019	BUY	$1.25 - $3.14 $936,805 - $2.35 Million	749,444 Added 70.22%	1,816,781 $2.74 Million
Q2 2019 Aug 14, 2019	BUY	$1.25 - $3.14 $774,761 - $1.95 Million	619,809 Added 138.5%	1,067,337 $2.14 Million
Q1 2019 May 14, 2019	SELL	$2.79 - $4.09 $2.23 Million - $3.27 Million	-800,509 Reduced 64.14%	447,528 $1.33 Million
Q4 2018 Feb 14, 2019	BUY	$3.23 - $7.01 $3.87 Million - $8.4 Million	1,197,642 Added 2376.51%	1,248,037 $4.19 Million
Q3 2018 Nov 14, 2018	SELL	$6.86 - $9.97 $840,617 - $1.22 Million	-122,539 Reduced 70.86%	50,395 $365,000
Q2 2018 Aug 14, 2018	SELL	$2.88 - $8.67 $372,337 - $1.12 Million	-129,284 Reduced 42.78%	172,934 $1.19 Million
Q1 2018 May 15, 2018	SELL	$2.92 - $3.81 $161,759 - $211,062	-55,397 Reduced 15.49%	302,218 $901,000
Q4 2017 Feb 14, 2018	BUY	$2.99 - $4.85 $514,776 - $835,005	172,166 Added 92.84%	357,615 $1.1 Million
Q3 2017 Nov 14, 2017	BUY	$3.01 - $5.41 $558,201 - $1 Million	185,449	185,449 $872,000

Others Institutions Holding VSTM

# of Institutions

Shares Held

297K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

225K
Shares

$852,750
0.14% of portfolio
Beaumont Financial Partners, LLC

48K
Shares

$181,920
0.0% of portfolio
Eaton Vance Management Boston, MA

20K
Shares

$75,800
0.0% of portfolio
American Portfolios Advisors Holbrook, NY

2.99K
Shares

$11,313
0.0% of portfolio
Brewin Dolphin Wealth Management LTD Conskleagh, Dublin, L2

1.07K
Shares

$4,070
0.0% of portfolio

View Full List

About Verastem, Inc.

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $796M
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

More about VSTM

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account